![1.jpg 1.jpg](/SupplyImg/2023-12-28/6383937923770350513938328.jpg)
DNAM1产品信息
物种:Human / Mouse / Cynomolgus / Canine
属性:Protein
标记:Biotin-labeled / Unconjugated
分子别名(Synonym)
DNAM1,CD226,PTA1
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>95% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 3 months under sterile conditions after reconstitution.
![2.jpg 2.jpg](/SupplyImg/2023-12-28/6383937924695503423547562.jpg)
DNAM1分子背景
DNAX辅助分子1(DNAM-1)是一种单程I型膜蛋白,也被称为CD226抗原和血小板和T细胞活化抗原1(PTA1),其中含有2个Ig样C2型(免疫球蛋白样)结构域。DNAM-1是一种约65 kDa的糖蛋白,在自然杀伤细胞、血小板、单核细胞和T细胞亚群的表面表达。DNAM-1介导细胞与携带其配体CD112和CD155的其他细胞的粘附,并将DNAM-1与抗体交联导致细胞活化。此外,DNAM-1可以与PVR和PVRL2相互作用。
关键字: DNAM1;DNAM1蛋白;CD226;CD226蛋白;DNAM-1;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。